Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Feasibility and Safety Study of Autologous Umbilical Cord Blood Cell Therapy in Infants With Neonatal Encephalopathy

NCT02256618 is registered in ClinicalTrials.gov with Neonatal Encephalopathy Consortium, Japan as lead sponsor.

NCT NCT02256618
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02256618 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Feasibility and Safety Study of Autologous Umbilical Cord Blood Cell Therapy in Infants With Neonatal Encephalopathy
Lead sponsor
Neonatal Encephalopathy Consortium, Japan
Phase
Phase 1
Overall status
Completed
Start date
August 31, 2014
Completion date
July 31, 2019
Enrollment
6 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

hypoxic-ischemic encephalopathy, neonatal encephalopathy